Angiotech to market Rex's Medicals's IVC filter
This article was originally published in Clinica
Executive Summary
Angiotech Pharmaceuticals has gained an exclusive worldwide licence to commercialise the Option inferior vena cava (IVC) filter, a device used to prevent recurrent pulmonary embolism.